U.S. Markets open in 1 hr, 4 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.5809 11:28 AM EST | |
|---|---|---|
| Day High | 0.65 03:07 PM EST |
|
| Range | 0.07 |
| Volume | 179,055 | |
|---|---|---|
| 30-Day Avg Vol | 138,000 |
|
| Difference | 29.75% |
| Market Cap | 11.36 M | |
|---|---|---|
| Mkt Cap Chg | 539,348 |
| Shares Out | 18.03 M | |
|---|---|---|
| % Shrs Traded | 0.99% | |
| 1yr EPS Est | -0.27 |
| 52-Wk Low | 0.39 | |
|---|---|---|
| 52-Wk High | 2.805 |
|
| Range | 2.42 |
| Prev Close | 0.60 2/8/10 | |
|---|---|---|
| Today's Open | 0.64 | |
| Change | 6.67% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 24,468.00 |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -10.56 M | |
| Earnings (MRQ) | -1.29 M | |
| Next Earn Est | -0.05 | |
| Next Earnings |
|
|
| EPS (TTM) | -0.70 | |
| 1yr EPS Growth | 61.97% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -78.87 | |
| Beta | 0.87 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Catalyst Pharmaceutical Partners may help certain addicts kick the habit. The development-stage company's lead candidate, CPP-109 (based on the chemical compound vigabatrin), is in clinical studies for ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.05 N/A | — — |
—
—
|
| Last Quarter | -0.105 9/30/09 | -0.09 9/30/09 |
0.015
Beat
|
| 2 Quarters Ago | -0.203 6/30/09 | -0.13 6/30/09 |
0.073
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -7,799.00 | -32,757.00 |
| Operating Income | -1.29 M | -10.89 M |
| Net Income | -1.29 M | -10.56 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts